Small molecule modulation of HH-GLI signaling: current leads, trials and tribulations
- PMID: 20412786
- DOI: 10.1016/j.bcp.2010.04.016
Small molecule modulation of HH-GLI signaling: current leads, trials and tribulations
Abstract
Many human sporadic cancers have been recently shown to require the activity of the Hedgehog-GLI pathway for sustained growth. The survival and expansion of cancer stem cells is also HH-GLI dependent. Here we review the advances on the modulation of HH-GLI signaling by small molecules. We focus on both natural compounds and synthetic molecules that target upstream pathway components, mostly SMOOTHENED, and those that target the last steps of the pathway, the GLI transcription factors. In this review we have sought to provide some bases for useful comparisons, listing original assays used and sources to facilitate comparisons of IC50 values. This area is a rapidly expanding field where biology, medicine and chemistry intersect, both in academia and industry. We also highlight current clinical trials, with positive results in early stages. While we have tried to be exhaustive regarding the molecules, not all data is in the public domain yet. Indeed, we have opted to avoid listing chemical structures but these can be easily found in the references given. Finally, we are hopeful that the best molecules will soon reach the patients but caution about the lack of investment on compounds that lack tight IP positions. While the market in developed nations is expected to compensate the investment and risk of making HH-GLI modulators, other sources or plans must be available for developing nations and poor patient populations. The promise of curing cancer recalls the once revered dream of El Dorado, which taught us that not everything that GLI-tters is gold.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy.Expert Rev Mol Med. 2015 Feb 9;17:e5. doi: 10.1017/erm.2015.3. Expert Rev Mol Med. 2015. PMID: 25660620 Free PMC article. Review.
-
Targeting GLI proteins in human cancer by small molecules (WO2014116651 A1): a patent evaluation.Expert Opin Ther Pat. 2015 May;25(5):613-7. doi: 10.1517/13543776.2015.1019467. Epub 2015 Mar 15. Expert Opin Ther Pat. 2015. PMID: 25772316
-
Protein kinase C-delta and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling.Cancer Res. 2006 Jan 15;66(2):839-45. doi: 10.1158/0008-5472.CAN-05-2539. Cancer Res. 2006. PMID: 16424016
-
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.Proc Natl Acad Sci U S A. 2007 May 15;104(20):8455-60. doi: 10.1073/pnas.0609699104. Epub 2007 May 9. Proc Natl Acad Sci U S A. 2007. PMID: 17494766 Free PMC article.
-
Interference with HH-GLI signaling inhibits prostate cancer.Trends Mol Med. 2005 May;11(5):199-203. doi: 10.1016/j.molmed.2005.03.004. Trends Mol Med. 2005. PMID: 15882606 Review.
Cited by
-
GLI1: A Therapeutic Target for Cancer.Front Oncol. 2021 May 25;11:673154. doi: 10.3389/fonc.2021.673154. eCollection 2021. Front Oncol. 2021. PMID: 34113570 Free PMC article. Review.
-
GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAFV600E Colorectal Cancer.Front Oncol. 2020 Feb 28;10:241. doi: 10.3389/fonc.2020.00241. eCollection 2020. Front Oncol. 2020. PMID: 32185127 Free PMC article.
-
Astragaloside IV promotes the proliferation and migration of osteoblast-like cells through the hedgehog signaling pathway.Int J Mol Med. 2019 Feb;43(2):830-838. doi: 10.3892/ijmm.2018.4013. Epub 2018 Dec 3. Int J Mol Med. 2019. PMID: 30535481 Free PMC article.
-
Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.Cancer Lett. 2017 Dec 28;411:136-149. doi: 10.1016/j.canlet.2017.09.033. Epub 2017 Sep 28. Cancer Lett. 2017. PMID: 28965853 Free PMC article.
-
Role of Hedgehog-Gli1 signaling in the enhanced proliferation and differentiation of MG63 cells enabled by hierarchical micro-/nanotextured topography.Int J Nanomedicine. 2017 Apr 20;12:3267-3280. doi: 10.2147/IJN.S135045. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28458545 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources